Biotech Values

[kamehameha]

We now know the lower the LDL the lower the CV risk

that's a bold assertion, some scientists certainly do not agree:

http://www.ncbi.nlm.nih.gov/pubmed/22253366

quote:
The Safety of Treating to LDL Targets Has Never Been Proven

In fact, when 10 international lipid experts, most of whom had previously advocated for an LDL-based approach, were asked to provide any reasonable scientific arguments that would result in a treat-to-target approach being as good as a tailored treatment approach, none were able to do so.6 This was not surprising, given that the RCT evidence clearly suggests that LDL does not help identify patients who are more likely to benefit from a statin.